Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
Hepatol Int. 2010 Jul 24;4(4):716-22. doi: 10.1007/s12072-010-9189-z.
Measuring liver stiffness is becoming more popular as a non-invasive tool for assessing liver fibrosis.
To assess the effect of severe hepatitis B flare on liver stiffness and determine factors that correlate with liver stiffness measurements.
Twenty-nine patients with severe hepatitis B flare (ALT > 10 × upper limit of normal) were followed up for 1 year. Serial transient elastography was performed at the time of flare, 3-6, and 12 months after flare.
At the time of flare, the median liver stiffness was 16.8 kPa, with no patients having normal liver stiffness (<6 kPa). There was a significant decrease in liver stiffness from baseline to 3-6 months (16.8 vs. 7.9 kPa, respectively, P < 0.001), and a further smaller decline from 3-6 to 12 months (7.9 vs. 6.9 kPa, respectively, P = 0.039). By 12 months, 10 (34%) had normalized their liver stiffness. Baseline parameters which correlated with liver stiffness include bilirubin, ALT, albumin, prothrombin time and platelet levels (all P < 0.05).
Liver stiffness was increased in patients with severe hepatitis B flares, with return to near normal levels by 6 months. Transient elastography for proper assessment of liver fibrosis should be performed at least 6 months after flare.
测量肝硬度作为一种评估肝纤维化的非侵入性工具越来越受欢迎。
评估乙型肝炎重度发作对肝硬度的影响,并确定与肝硬度测量相关的因素。
对 29 例乙型肝炎重度发作(ALT>10×正常值上限)患者进行了为期 1 年的随访。在发作时、发作后 3-6 个月和 12 个月进行了多次瞬时弹性成像。
在发作时,中位数肝硬度为 16.8kPa,无患者肝硬度正常(<6kPa)。与基线相比,3-6 个月时肝硬度显著下降(分别为 16.8 与 7.9kPa,P<0.001),3-6 个月至 12 个月时进一步下降(分别为 7.9 与 6.9kPa,P=0.039)。12 个月时,10 例(34%)患者肝硬度恢复正常。与肝硬度相关的基线参数包括胆红素、ALT、白蛋白、凝血酶原时间和血小板水平(均 P<0.05)。
乙型肝炎重度发作患者的肝硬度增加,6 个月后接近正常水平。在发作后至少 6 个月进行瞬时弹性成像以适当评估肝纤维化。